|
1
|
Afshar-Kharghan V: Atypical hemolytic
uremic syndrome. Hematol Am Soc Hematol Educ Prog. 2016:217–225.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Salvadori M and Bertoni E: Update on
hemolytic uremic syndrome: Diagnostic and therapeutic
recommendations. World J Nephrol. 2:56–76. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jokiranta TS: HUS and atypical HUS. Blood.
129:2847–2856. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gasser C, Gautier E, Steck A, Siebenmann
RE and Oechslin R: Hemolytic-uremic syndrome: Bilateral necrosis of
the renal cortex in acute acquired hemolytic anemia. Schweiz Med
Wochenschr. 85:905–909. 1955.PubMed/NCBI
|
|
5
|
Lee H, Kang E, Kang HG, Kim YH, Kim JS,
Kim HJ, Moon KC, Ban TH, Oh SW, Jo SK, et al: Consensus regarding
diagnosis and management of atypical hemolytic uremic syndrome.
Korean J Intern Med. 35:25–40. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Aldharman SS, Almutairi SM, Alharbi AA,
Alyousef MA, Alzankrany KH, Althagafi MK, Alshalahi EE, Al-Jabr KH,
Alghamdi A and Jamil SF: The Prevalence and incidence of hemolytic
uremic syndrome: A systematic review. Cureus.
15(e39347)2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Roumenina LT, Loirat C, Dragon-Durey MA,
Halbwachs-Mecarelli L, Sautes-Fridman C and Fremeaux-Bacchi V:
Alternative complement pathway assessment in patients with atypical
HUS. J Immunol Methods. 365:8–26. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rondeau E, Ardissino G, Caby-Tosi MP,
Al-Dakkak I, Fakhouri F, Miller B and Scully M: Global aHUS
Registry. Pregnancy in women with atypical hemolytic uremic
syndrome. Nephron. 146:1–10. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ávila A, Cao M, Espinosa M, Manrique J and
Morales E: Recommendations for the individualised management of
atypical hemolytic uremic syndrome in adults. Front Med (Lausanne).
10(1264310)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yan K, Desai K, Gullapalli L, Druyts E and
Balijepalli C: Epidemiology of atypical hemolytic uremic syndrome:
A systematic literature review. Clin Epidemiol. 12:295–305.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yerigeri K, Kadatane S, Mongan K, Boyer O,
Burke LLG, Sethi SK, Licht C and Raina R: Atypical Hemolytic-uremic
syndrome: Genetic basis, clinical manifestations, and a
multidisciplinary approach to management. J Multidiscip Healthc.
16:2233–2249. 2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang K, Lu Y, Harley KT and Tran MH:
Atypical hemolytic uremic syndrome: A brief review. Hematol Rep.
9(7053)2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bayer G, von Tokarski F, Thoreau B,
Bauvois A, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D,
Bernard L, et al: Etiology and outcomes of thrombotic
microangiopathies. Clin J Am Soc Nephrol. 14:557–566.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sheerin NS and Glover E: Haemolytic uremic
syndrome: Diagnosis and management. F1000Res 8: F1000 Faculty
Rev-1690, 2019.
|
|
15
|
Scully M and Goodship T: How I treat
thrombotic thrombocytopenic purpura and atypical haemolytic uraemic
syndrome. Br J Haematol. 164:759–766. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Domínguez-Vargas A, Ariño F, Silva D,
González-Tórres HJ, Aroca-Martinez G, Egea E and Musso CG:
Pregnancy-associated atypical hemolytic uremic syndrome: A case
report with MCP gene mutation and successful eculizumab treatment.
AJP Rep. 14:e96–e100. 2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tseng MH, Lin SH, Tsai JD, Wu MS, Tsai IJ,
Chen YC, Chang MC, Chou WC, Chiou YH and Huang CC: Atypical
hemolytic uremic syndrome: Consensus of diagnosis and treatment in
Taiwan. J Formos Med Assoc. 122:366–375. 2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ardissino G, F, Possenti I, Testa S,
Consonni D, Paglialonga F, Salardi S, Borsa-Ghiringhelli N, Salice
P, Tedeschi S, et al: Early volume expansion and outcomes of
hemolytic uremic syndrome. Pediatrics: Dec 7, 2016 (Epub ahead of
print). doi: 10.1542/peds.2015-2153.
|
|
19
|
Leon J, LeStang MB, Sberro-Soussan R,
Servais A, Anglicheau D, Frémeaux-Bacchi V and Zuber J:
Complement-driven hemolytic uremic syndrome. Am J Hematol. 98
(Suppl 4):S44–S56. 2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Valoti E, Alberti M, Iatropoulos P, Piras
R, Mele C, Breno M, Cremaschi A, Bresin E, Donadelli R, Alizzi S,
et al: Rare functional variants in complement genes and Anti-FH
Autoantibodies-associated aHUS. Front Immunol.
10(853)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Piras R, Valoti E, Alberti M, Bresin E,
Mele C, Breno M, Liguori L, Donadelli R, Rigoldi M, Benigni A, et
al: CFH and CFHR structural variants in atypical Hemolytic Uremic
Syndrome: Prevalence, genomic characterization and impact on
outcome. Front Immunol. 13(1011580)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Valério P, Barreto JP, Ferreira H, Chuva
T, Paiva A and Costa JM: Thrombotic microangiopathy in oncology-a
review. Transl Oncol. 14(101081)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Schwotzer N, Frémeaux-Bacchi V and
Fakhouri F: Hemolytic uremic syndrome: A question of terminology.
Clin J Am Soc Nephrol. 18:831–833. 2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wildes DM, Harvey S, Costigan CS, Sweeney
C, Twomey É, Awan A and Gorman KM: Eculizumab in STEC-HUS: A
paradigm shift in the management of pediatric patients with
neurological involvement. Pediatr Nephrol. 39:315–324.
2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Stefanovic V: The Extended use of
eculizumab in pregnancy and complement activation(-)associated
diseases affecting maternal, fetal and neonatal kidneys-the future
is now? J Clin Med. 8(407)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Timmermans SAMEG, Abdul-Hamid MA,
Potjewijd J, Theunissen ROMFIH, Damoiseaux JGMC, Reutelingsperger
CP and van Paassen P: Limburg Renal Registry. C5b9 formation on
endothelial cells reflects complement defects among patients with
renal thrombotic microangiopathy and severe hypertension. J Am Soc
Nephrol. 29:2234–2243. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Secretaría de Salud México: Frequently
asked questions: Seasonal influenza [Internet]. Mexico City:
Government of Mexico. In Spanish. Available from: https://www.gob.mx/salud/acciones-y-programas/preguntas-frecuentes-influenzaestacional.
|
|
28
|
Kottke-Marchant K: Diagnostic approach to
microangiopathic hemolytic disorders. Int J Lab Hematol. 39 (Suppl
1):S69–S75. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Avila Bernabeu AI, Cavero Escribano T and
Cao Vilarino M: Atypical hemolytic uremic syndrome: New challenges
in the complement blockage era. Nephron. 144:537–549.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Saad AF, Roman J, Wyble A and Pacheco LD:
Pregnancy-associated atypical hemolytic-uremic syndrome. AJP Rep.
6:e125–e128. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Konopásek P and Zieg J: Eculizumab use in
patients with pneumococcal-associated hemolytic uremic syndrome and
kidney outcomes. Pediatr Nephrol. 38:4209–4215. 2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Miyazaki Y, Fukuda M, Hirayu N, Nabeta M
and Takasu O: Pregnancy-associated atypical hemolytic uremic
syndrome successfully treated with ravulizumab: A case report.
Cureus. 16(e54207)2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mirza M, Sadiq N and Aye C:
Pregnancy-associated atypical hemolytic uremic syndrome and
Life-long kidney failure. Cureus. 14(e25655)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Che M, Moran SM, Smith RJ, Ren KYM, Smith
GN, Shamseddin MK, Avila-Casado C and Garland JS: A case-based
narrative review of pregnancy-associated atypical hemolytic uremic
syndrome/complement-mediated thrombotic microangiopathy. Kidney
Int. 105:960–970. 2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Java A: Atypical hemolytic uremic
syndrome: Diagnosis, management, and discontinuation of therapy.
Hematology Am Soc Hematol Educ Program. 2024:200–205.
2024.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gaire S, Shrestha M, Bhattarai CD,
Dhungana S, Gyawali S and Bajgain A: Hemolytic uremic syndrome: A
case report. JNMA J Nepal Med Assoc. 61:472–474. 2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Raina R, Krishnappa V, Blaha T, Kann T,
Hein W, Burke L and Bagga A: Atypical Hemolytic-uremic syndrome: An
update on pathophysiology, diagnosis, and treatment. Ther Apher
Dial. 23:4–21. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kaplan BS, Ruebner RL, Spinale JM and
Copelovitch L: Current treatment of atypical hemolytic uremic
syndrome. Intractable Rare Dis Res. 3:34–45. 2024.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Cofiell R, Kukreja A, Bedard K, Yan Y,
Mickle AP, Ogawa M, Bedrosian CL and Faas SJ: Eculizumab reduces
complement activation, inflammation, endothelial damage,
thrombosis, and renal injury markers in aHUS. Blood. 125:3253–3262.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Yang L, Liu F, Li X, He L, Gu Y, Sun M and
Liu Z and Liu Z: Plasma exchange combined with eculizumab in the
management of atypical hemolytic uremic in pediatric patients: A
case report. Medicine (Baltimore). 104(e42090)2025.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Loirat C, Garnier A, Sellier-Leclerc AL
and Kwon T: Plasmatherapy in atypical hemolytic uremic syndrome.
Semin Thromb Hemost. 36:673–81. 2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Frimat M, Gnemmi V, Stichelbout M, Provôt
F and Fakhouri F: Pregnancy as a susceptible state for thrombotic
microangiopathies. Front Med (Lausanne). 11(1343060)2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
De Meyer F, Chambaere K, Van de Velde S,
Van Assche K, Beernaert K and Sterckx S: Factors influencing
obstetricians' acceptance of termination of pregnancy beyond the
first trimester: A qualitative study. BMC Med Ethics.
26(32)2025.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Fakhouri F: Pregnancy-related thrombotic
microangiopathies: Clues from complement biology. Transfus Apher
Sci. 54:199–202. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Fakhouri F, Fila M, Hummel A, Ribes D,
Sellier-Leclerc AL, Ville S, Pouteil-Noble C, Coindre JP, Le
Quintrec M, Rondeau E, et al: Eculizumab discontinuation in
children and adults with atypical hemolytic-uremic syndrome: A
prospective multicenter study. Blood. 137:2438–2449.
2021.PubMed/NCBI View Article : Google Scholar
|
